Uveal melanoma is an intraocular malignancy that, depending on its size and genetic make-
up, may lead to metastases in up to 50% of cases. Currently, no therapy has been proven to …

Uveal melanoma is the most prevalent primary intraocular tumour in adults with the
incidence between five and six cases per million people in the United States and Europe …

Background: Uveal melanoma is the most common primary intraocular malignancy among
adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per …

Background: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor
prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors …

Uveal melanoma is a malignancy with exceptional features for treatment with
immunotherapy. Primary uveal melanoma can be treated with a variety of therapies that may …

Introduction Uveal melanoma (UM) is the most common intraocular cancer and represents a
discrete subtype of melanoma. Metastatic disease, which occurs in half of patients, has a …

Uveal melanoma (UM) is a rare cancer arising from melanocytes in the uveal tract of the eye.
Despite effective primary treatment, there is no approved therapy for metastatic UM and …

Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Uveal melanoma is the most common primary intraocular tumor in adults. 1 Before the mid-
20th century, enucleation was the mainstay of treatment for uveal melanoma. Although this …

Uveal melanoma (UM) is one of the rare malignancies, which can be lethal despite local
treatment. Treatment options available now can control UM in early stages, but once it …